Apoptosis Imaging in Oncology by Means of Positron Emission Tomography: A Review
To date, a wide variety of potential PET-apoptosis imaging radiopharmaceuticals targeting apoptosis-induced cell membrane asymmetry and acidification, as well as caspase 3 activation (substrates and inhibitors) have been developed with the purpose of rapidly assessing the response to treatment in ca...
Main Authors: | Christophe Van de Wiele, Sezgin Ustmert, Bart De Spiegeleer, Pieter-Jan De Jonghe, Mike Sathekge, Maes Alex |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-03-01
|
Series: | International Journal of Molecular Sciences |
Subjects: | |
Online Access: | https://www.mdpi.com/1422-0067/22/5/2753 |
Similar Items
-
PSMA-Targeting Positron Emission Agents for Imaging Solid Tumors Other Than Non-Prostate Carcinoma: A Systematic Review
by: Christophe Van de Wiele, et al.
Published: (2019-10-01) -
Radiolabelled Peptides for Positron Emission Tomography and Endoradiotherapy in Oncology
by: Christine Rangger, et al.
Published: (2020-01-01) -
POSITRON EMISSION TOMOGRAPHY IN GYNECOLOGIC ONCOLOGY
by: D. V. Ryzhkova, et al.
Published: (2016-02-01) -
Immuno-positron emission tomography with zirconium-89-labeled monoclonal antibodies in oncology
by: Yvonne W.S. Jauw, et al.
Published: (2016-05-01) -
Positron Emission Tomography (PET) in Oncology
by: Andrea Gallamini, et al.
Published: (2014-09-01)